3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)Fátima Cardoso, Eric P. Winer, N. El Saghir et al.|Annals of Oncology|2016Cited by 2.1k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> MutationBella Kaufman, Susan M. Domchek, Ronnie Shapira‐Frommer et al.|Journal of Clinical Oncology|2014Cited by 1.7k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)Fátima Cardoso, Eric P. Winer, Shani Paluch–Shimon et al.|Annals of Oncology|2020Cited by 1.4k
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)Fátima Cardoso, E.P. Winer, Elżbieta Senkus et al.|Annals of Oncology|2018Cited by 1.2k
Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM StudyBella Kaufman, Alison Jones, John R. Mackey et al.|Journal of Clinical Oncology|2009Cited by 850